MISEQ DX NGS SEQUENCER

The MiSeqDx instrument is the first FDA-cleared in vitro diagnostic & next-generation sequencing (NGS) system. Illumina also received FDA premarket clearance for the MiSeqDx Cystic Fibrosis 139-Variant Assay, MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, and MiSeqDx Universal Kit. *Certified with 90-day warranty (US and Canada ONLY)